comparemela.com

Latest Breaking News On - Carmot therapeutics - Page 10 : comparemela.com

Carmot acquisition propels Roche to forefront of obesity drug leadership

In a significant move in December 2023, Roche completed the acquisition of the US-based company Carmot Therapeutics in a deal worth $2.9 billion.

Eli lillySourabh nyalkalkarTechnology foresightsNovo nordiskCarmot therapeuticsBio developmentsMarkets amp regulationsEmerging marketsEli lilly

Roche is on par with Novo, Lilly in GLP-1 race after $2 7B Carmot deal

By picking up Carmot and its three lead molecules Roche is on par with the current leaders in the obesity drug space.

Eli lillySourabh nyalkalkarNovo nordiskTechnology foresightsCarmot therapeutics

Roche Hunts for More Deals to Challenge Lilly, Novo on Obesity

Roche Hunts for More Deals to Challenge Lilly, Novo on Obesity
bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.

San franciscoUnited statesLilly zepboundNovo nordiskJames sabryNovo wegovyBloomberg roche holdingCarmot therapeutics incEli lilly coCarmot therapeuticsEli lillyHealthcare conferenceObesity drug investors get windfallRoche joins

Swiss Pharma Giants Plot Different Paths for Next Blockbuster Drugs

Swiss Pharma Giants Plot Different Paths for Next Blockbuster Drugs
bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.

United statesSan franciscoDavid samraNovo nordiskBloomberg europeTeresa grahamSabah meddingsPaulo fontouraSeverin schwanThomas schineckerMckinsey coPharmaceuticals indexSandoz groupCarmot therapeutics incAlcon incRoche holding

Pharma obesity market: Roche seeks deals to challenge Lilly and Novo

Roche isn’t done making moves in the obesity market after last month’s agreement to buy Carmot Therapeutics Inc. for $3.1 billion (CHF2.64 billion).

San franciscoUnited statesLilly zepboundJames sabryNovo wegovyNovo nordiskCarmot therapeutics incRoche holdingEli lilly coCarmot therapeuticsEli lillyHealthcare conferenceLatest newsPreventative medicineMedical researchPrivate health care

vimarsana © 2020. All Rights Reserved.